BioMed Realty, the life science arm of New York-based Blackstone, is planning another project in South Lake Union, assembling two parcels in the latest injection of biotech investment into Seattle’s longtime tech industry nerve center.
BioMed Realty, the life science arm of New York-based Blackstone, is planning another project in South Lake Union, assembling two parcels in the latest injection of biotech investment into Seattle’s longtime tech industry nerve center.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
2300 7th Ave, Seattle, WA
200 Taylor Ave, Seattle, WA
Finance and Insurance
Real Estate